Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 24, 2004
Association of progesterone receptor polymorphism with recurrent abortionsAndreas Schweikert, Thomas Rau, Alexander Berkholz, et al.
Clinical Pharmacology and Therapeutics|November 23, 2006
High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrationsThomas Rau, Birgit Erney, Ralf Göres, et al.
Clinical Pharmacology and Therapeutics|August 2, 2003
Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humansUlrike Werner, Dierk Werner, Thomas Rau, et al.
The Journal of Biological Chemistry|March 11, 2004
Formation of molecular complexes by N-methyl-D-aspartate receptor subunit NR2B and ryanodine receptor 2 in neonatal rat myocardSilke Seeber, Andreas Humeny, Matthias Herkert, et al.
Clinical Pharmacology and Therapeutics|April 30, 2004
CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot studyThomas Rau, Gerlinde Wohlleben, Henrike Wuttke, et al.
Clinical Pharmacology and Therapeutics|September 11, 2003
Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenacBurkhard Hinz, Thomas Rau, Daniel Auge, et al.
Epilepsy Research|October 5, 2018
Convulsive seizures and EEG spikes after lateral fluid-percussion injury in the ratDebbie Smith, Thomas Rau, Austin Poulsen, et al.
Pharmacogenetics|August 13, 2002
Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatmentThomas Rau, Roland Heide, Klaus Bergmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatmentJens Köllermann, Steffen Weikert, Martin Schostak, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 15, 2008
Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veinsMartin W Huellner, Sonja Schrepfer, Michael Weyand, et al.
Pageof 6